| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000038954 |
| Receipt No. | R000044423 |
| Scientific Title | Study on characteristics and usefulness of breast DWI. |
| Date of disclosure of the study information | 2020/01/01 |
| Last modified on | 2019/12/22 (Ver. 1) |
| Basic information | ||
| Public title | Study on characteristics and usefulness of breast DWI. | |
| Acronym | Study on characteristics and usefulness of breast DWI. | |
| Scientific Title | Study on characteristics and usefulness of breast DWI. | |
| Scientific Title:Acronym | Study on characteristics and usefulness of breast DWI. | |
| Region |
|
|
| Condition | ||
| Condition | Breast lesions | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Non-contrast MRI DWI images are expected to be a noninvasive screening test for breast cancer high-risk groups, but are known to have low lesion delineation output.
In this study, we examine the features and usefulness of DWI imaging by examining cases in which histological examination was performed for mammography MRI and breast lesions. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | To evaluate the differential diagnostic ability of DWI images for benign or malignant breast lesions. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Cases who have undergone contrast-enhanced MRI and have confirmed histopathological diagnosis.
2. Patients who did not refuse inclusion in this clinical trial. |
|||
| Key exclusion criteria | 1. Patients without contrast-enhanced MRI or clinicopathological diagnosis.
2. Patients who refused to be included in this clinical trial. |
|||
| Target sample size | 150 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | SUNKOKAI KOGA Hospital | ||||||
| Division name | Breast Surgery | ||||||
| Zip code | 425-0088 | ||||||
| Address | 2-30-1, Daikakuji, Yaizu-shi, Shizuoka | ||||||
| TEL | 0546285500 | ||||||
| shikanazawa-gi@umin.net | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | SUNKOKAI KOGA Hospital | ||||||
| Division name | Breast Surgery | ||||||
| Zip code | 425-0088 | ||||||
| Address | 2-30-1, Daikakuji, Yaizu-shi, Shizuoka | ||||||
| TEL | 0546285500 | ||||||
| Homepage URL | |||||||
| shikanazawa-gi@umin.net | |||||||
| Sponsor | |
| Institute | SUNKOKAI KOGA Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | SUNKOKAI KOGA Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | SUNKOKAI KOGA Hospital |
| Address | 2-30-1, Daikakuji, Yaizu-shi, Shizuoka |
| Tel | 0546285500 |
| shikanazawa-gi@umin.net | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | None |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044423 |